Up to 80% of CRCs carries APC mutation, as a result, β-catenin accumulates, translocates to the nucleus, and associates with TCF/LEF, leading to subsequent transcriptional activation of genes associated with CRC development [30, 31]. This evidence concerns the gene HNF4A and colorectal carcinoma.